XiaoMi-AI文件搜索系统
World File Search System科查
iFreeETF 中国科创板50（STAR50）（2104）
■申请ETF时，一定要查看《投资信托说明书》的内容，并自行做出决定。 ■由于投资信托投资于价值波动的证券等资产，因此单位价格波动较大。因此，投资本金得不到保障。信托财产产生的全部盈亏均属于投资人所有。投资信托与储蓄账户不同。 ■与存款和保险合同不同，投资信托不受存款保险公司或保险单持有人保护公司的保护。通过证券公司以外的其他方式购买的投资信托不受投资者保护基金的保护。 ■分配金额由管理公司根据收益分配政策决定。无法保证提前分配固定金额。在某些情况下，可能不会支付股息。 ■本材料来自我们认为可靠的来源，但我们不保证其准确性或完整性。所提供的有关业绩等的信息基于过去的表现，并不暗示或保证未来的结果。本文所述指数、统计数据等的所有知识产权和其他权利均属于发行人和许可人所有。此外，由于它并未考虑税费等，因此并不代表投资者的实际投资结果。内容在撰写时是最新的，如有更改，恕不另行通知。 ■如果本文件中提及个别公司名称，则仅供参考，并不代表对任何公司的认可。
Jacobio Pharmaceuticals Group Co。，Ltd。 加科思...
1L NSCLC（与JAB-3312，Jacobio的SHP2抑制剂结合使用） - Glecirasib的I/IIA期试验与本地晚期或携带具有KRAS G12C突变的局部晚期或转移性晚期实体瘤中的JAB-3312结合使用。探索了具有不同剂量水平和频率的七个剂量方案。 2023年10月在西班牙马德里举行的2023年欧洲医学肿瘤学学会（ESMO）大会上有144例患者的新兴安全性和效力数据。探索了具有不同剂量水平和频率的七个剂量方案。2023年10月在西班牙马德里举行的2023年欧洲医学肿瘤学学会（ESMO）大会上有144例患者的新兴安全性和效力数据。截至本公告之日，携带KRAS G12C突变的局部晚期或转移性实体瘤患者约有200例接受了Glecirasib和Jab-3312的组合治疗。在所有患者接受联合疗法中，约有100名患者是1L NSCLC患者。长期安全和效力数据已提交给2024年美国临床肿瘤学会（ASCO）年度会议。
空军航空技术学院114年「国军二技军官班」招生简章
定。但获准易科罚金、易服社会劳动执行完毕、缓刑期满而缓刑之宣 定。但获准易科罚金、易服社会劳动执行完毕、缓刑期满而缓刑之宣，或符合少年事件处理法第83条之1第1项规定者，不在（四）体格检查不符「国军二技军官班体检体格区分表（如附录1）」基准。（如附录）」基准。（五）报考「推荐入学」及「申请入学」，二技统一入学测验任一科成绩零分。，二技统一入学测验任一科成绩零分。（六）一般生报考之附加条件：
马查科斯县年度发展计划，2025-2026
表2。1: Agriculture and Co-operative Development Sector Analysis of CADP 2024/2025 Allocation against Approved Budget 2024/2025 .................................................................................................................................... 9 Table 2.2: Commercial, Tourism and Labour Affairs Sector Analysis of CADP 2024/2025 Allocation against Approved Budget 2024/2025 .................................................................................................................................. 11 Table 2.3: Education, Youth and Social Welfare Sector Analysis of CADP 2024/2025 Allocation against Approved Budget 2024/2025 .................................................................................................................................................. 13 Table 2.4: Energy, Infrastructure and ICT Sector Analysis of CADP 2024/2025 Allocation against Approved Budget 2024/2025 .................................................................................................................................................. 17 Table 2.5：CADP 2024/2025卫生部门分析针对批准预算的分配2024/2025 ........................................................................................... 17表2。6: Land, Environment and Natural Resources Sector Analysis of CADP 2024/2025 Allocation against Approved Budget 2024/2025 .................................................................................................................................. 27 Table 2.9：2023/2024财年的收入绩效分析................................................................................................................................................................................................................................................................................................................................................................................................. 35表27: Public Administration Sector Analysis of CADP 2024/2025 Allocation against Approved Budget 2024/2025 .............................................................................................................................................................. 31 Table 2.8: Water and Irrigation Sector Status Analysis of CADP 2024/2025 Allocation against Approved Budget 2024/2025 .............................................................................................................................................................. 33 Table 2.10: Expenditure Analysis .......................................................................................................................... 36 Table 2.11: Linkages with National Development Agenda, Regional and International Development Frameworks ............................................................................................................................................................................. 137 Table 3.1：农业和合作发展部门计划的摘要............................................................................................................................................................................................................................................................................................................................................................................................. 184表3。2：2025/2026财年的农业和合作开发部门项目...................................................................................................................................................................................................................................................................................................................................................3: Summary of Commercial, Tourism and Labour Affairs Sector Programmes ........................................ 196 Table 3.4: Commercial, Tourism and Labour Affairs Sector Projects for the FY 2025/2026 ................................ 206 Table 3.5：教育，青年和社会福利部门计划的摘要..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................6: Education, Youth and Social Welfare Sector Projects for the FY 2025/2026 ....................................... 219 Table 3.7: Summary of Energy, Infrastructure and ICT Sector Programmes ........................................................ 227 Table 3.8：2025/2026财年的能源，基础设施和ICT部门项目............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 231表3。9：卫生部门计划的摘要........................................................................................................................................................................................................................................................................................................................................................... 238表3。10: Health Sector Projects for the FY 2025/2026 ..................................................................................... 254 Table 3.11: Summary of Land, Environment and Natural Resources Sector Programmes .................................... 257 Table 3.12：2025/2026财年土地，环境和自然资源部门项目..................................................................................................................................................................................................................................................................................................................................................................................... 265表3。13: Summary of Public Administration Sector Programmes .................................................................... 273 Table 3.14：2025/2026财年的公共行政部门项目................................................................................................................................................................................................................................................................................................................................... 286表3。15: Summary of Water and Irrigation Sector Programmes ....................................................................... 291 Table 3.16：2025/2026财年的水和灌溉部门项目................................................................................................................................................................................................................................................................................................................................................................................................................................................. 293表3。17: Proposed Grants, Benefits and Subsidies to be Issued ........................................................................ 301 Table 3.18: Linkages with National Development Agenda, Regional and International Development Frameworks ............................................................................................................................................................................. 301
广东力科新能源有限公司Guangdong Pow-Tech New Power ...
Constant current 0.2C charge to FC Voltage, then constant voltage FC Voltage charge to current declines to 0.02C, rest for 10min, constant current 0.2C discharge to 2.8V, rest for 10min.Repeat above steps till continuously discharge capacity higher than 80% of the initial capacity of the battery.电池以0.2C 充饱，静置10 分钟，然后以0.2C 放空， 静置10 分钟。重复以上充放电循环直至放电容量低于初 始容量的80%。
京都制药大学的教育研究成就记录
Professor Associate Professor Lecturer Assistant Professor Assistant President Goto Naomasa Vice President Akaji Kenichi Pharmaceutical Chemistry Furuta Takumi Kobayashi Yusuke Hamada Shohei Pharmaceutical Manufacturing Yamashita Masayuki Kojima Naoto Iwasaki Hiroki Pharmaceutical Chemistry Oishi Shinya Kobayashi Kazuya Herbal Medicine Nakamura Masahiro Pharmaceutical Analysis Takekami Shigehiko Konishi Atsuko Metabolic Analysis Yasui Hiroyuki Kimura Hiroyuki Naito Yukiyoshi Pharmaceutical Physical Chemistry Saito Hiroyuki Nagao Kojiro Ogita Takashi Takayama Takaya Morito Katsuya Public Health Watanabe Tetsushi Matsumoto Takahiro Microbiology and Infection Control Yahiro Kinnosuke Kamoshida Tsuyoshi Cell Biology Fujimuro Masahiro Sekine Yuichi Biochemistry Nakayama Yuji Saito Yohei Yuki Ryuzaburo Pathophysiology Ashihara Eiji Hosoki Masayuki Toda Yuki Pathobiochemistry Akiba Satoshi Ishihara Keiichi Kawashita Eri Pharmacology Kato Shinichi Matsumoto Kenjiro Yasuda Hiroyuki Clinical pharmacology Nakata Tetsuo Ohara Yuki Toba Yue Pharmacology Tanaka Tomoyuki Fujii Masanori Tamura Yuho Clinical oncology Nakata Shinshin Ii Hiromi山原药理学MASARU KATSUMI EIMASA MORISHITA MASATERU药理学EITA tomoyuki Ito ito Yukako Kawabuchi Kawabuchi Shinji临床药理学Westguchi koji koji tsujimoto Sciences Nagasawa Yoshinori Tanahashi Takaichiro Physics Arimoto Shigeru Mathematics Ueno Yoshio General Education Sato Takeshi Imai Chiju Iwasaki Daisuke Asahina Yuko Mimikawa Mariko Sakamoto Naoshi Kishino Ryoji Nozaki Akiko Pharmaceutical Education Research Center Hosoi Nobuzo Kai Akihiro Yoshimura Noriko临床药物教育研究中心Kusumoto Masaaki Tsushima Miyuki Imanishi takashi takasaki chizaki yugo yugo hashizume tsutomu tsutomu nakamura nakamura nobuhiko nobuhiko yano yano yano yano yano yano yano yano yano yano yano matsumura matsumura chikaka chikako chikako intraption trienlation triping sesight inij issey CENTERIOD教育研究中心。中心（Fujiwara Yoichi）Kimura Toru Kinseong Kaoru Tokuyama Yuki Yuki kono kono kyoko takao takao ikuko tokada tetsuya hirayama hirayama eetsuko图书馆（西exit exit koji koji koji koji） Kawashima Hidekazu生物科学研究中心（Kato Shinichi）Saito Michiko Pharmaceutical Science Frontier Research Center（Yamashita Masayuki）联合设备中心（Furuta Takumi）
广东力科新能源有限公司Guangdong Pow-Tech New Power ...
Constant current 0.2C charge to FC Voltage, then constant voltage FC Voltage charge to current declines to 0.02C, rest for 10min, constant current 0.2C discharge to 2.8V, rest for 10min. Repeat above steps till continuously discharge capacity higher than 80% of the initial capacity of the battery. 电池以0.2C 充饱，静置10 分钟，然后以0.2C 放空， 静置10 分钟。重复以上充放电循环直至放电容量低于初 始容量的80%。
望 尘科 技 控 股 有限 公 司 - :: HKEX :: HKEXnews ::
发售价预期将于 2023 年 1 月 6 日星期五左右由我们与独家保荐人兼总协调人（代表承销商）协商确定，且无论如何不迟于 2023 年 1 月 13 日星期五。若因任何原因，我们与独家保荐人兼总协调人（代表承销商）未能于 2023 年 1 月 13 日星期五（香港时间）或之前就发售价达成一致，则全球发售（包括香港公开发售）将不会进行并失效。除非另有公布，否则发售价将不超过每股发售股份 7.16 港元，目前预期将不低于每股发售股份 5.7 港元。申请香港发售股份的投资者须于申请时支付最高发售价每股发售股份 7.16 港元，另加 1.0% 经纪佣金、0.0027% 证监会交易征费、0.00565% 香港联交所交易费及 0.00015% AFRC 交易征费；若发售价低於每股发售股份 7.16 港元，则有关款项可获退还。